Novabay Pharmaceuticals Inc. (NBY) NYSE MKT LLC
$0.07 (0.01) (-12.02%)
Market Cap: $2.97M
As of 04/22/24 04:00 PM EDT. Market closed.
Novabay Pharmaceuticals Inc. (NBY)
NYSE MKT LLC
$0.07
(0.01) (-12.02%)
Market Cap: $2.97M
As of 04/22/24 04:00 PM EDT. Market closed.
Add to Portfolio
novabay pharmaceuticals $nby is a biopharmaceutical company focusing, commercializing and developing its non-antibiotic anti-infective products to address the unmet therapeutic needs of the global eye care market. novabay has two distinct product categories: the neutrox™ family of products, led by avenova™ for the eye care market, neutrophase® for wound care, and cellerx™ for the ... read more
COMPANY PROFILE
Sector
Industry
CEO
Justin Hall
Full Time Employees
56
Sector
Industry
CEO
Justin Hall
Full Time Employees
56
URL
Address
2000 Powell St Ste 1150, California, Emeryville, 94608-1804.
PRICE CHART FOR NOVABAY PHARMACEUTICALS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.08
Previous Close
$0.08
Days Range
$0.07 - $0.09
52 week range
$0.07 - $1.52
Volume
3,952,287
Avg. Volume (30 days)
3,350,242
Market Cap
$2.97M
Dividend Yield
-
P/E
-
Shares Outstanding
36,060,825
Open
$0.08
Previous Close
$0.08
Days Range
$0.07 - $0.09
52 week range
$0.07 - $1.52
Volume
3,952,287
Avg. Volume (30 days)
3,350,242
Market Cap
$2.97M
Dividend Yield
-
P/E
-
Shares Outstanding
36,060,825
FINANCIAL STATEMENTS FOR NOVABAY PHARMACEUTICALS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR NOVABAY PHARMACEUTICALS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Kunin Audrey | Chief Product Officer | Dec 06, 2022 | Sale | $1.81 | 1 | 2 | 0 | Dec 07, 2022, 04:55 PM |
| Kunin Jeffrey | President, DERMAdoctor, LLC | Dec 06, 2022 | Sale | $1.81 | 1 | 2 | 0 | Dec 07, 2022, 04:55 PM |
| Kunin Audrey | Chief Product Officer | Nov 21, 2022 | Sale | $2.10 | 5,960 | 12,545 | 1 | Dec 05, 2022, 05:30 PM |
| Kunin Jeffrey | President, DERMAdoctor, LLC | Nov 21, 2022 | Sale | $2.10 | 5,960 | 12,545 | 1 | Dec 05, 2022, 05:30 PM |
| Kunin Audrey | Chief Product Officer | Nov 21, 2022 | Sale | $2.10 | 5,960 | 12,545 | 0 | Nov 23, 2022, 04:16 PM |
| Kunin Jeffrey | President, DERMAdoctor, LLC | Nov 21, 2022 | Sale | $2.10 | 5,960 | 12,545 | 0 | Nov 23, 2022, 04:15 PM |
| Hall Justin | CEO, GC and Director | Sep 14, 2022 | Buy | $0.15 | 10,000 | 1,500 | 83,172 | Sep 16, 2022, 08:45 PM |
| Kunin Jeffrey | President, DERMAdoctor, LLC | Sep 14, 2022 | Sale | $0.16 | 291,368 | 46,094 | 208,632 | Sep 16, 2022, 06:26 PM |
| Kunin Audrey | Chief Product Officer | Sep 14, 2022 | Sale | $0.16 | 291,368 | 46,094 | 208,632 | Sep 16, 2022, 06:24 PM |
| Kunin Jeffrey | President, DERMAdoctor, LLC | Dec 03, 2021 | Buy | $0.46 | 101,650 | 47,013 | 500,000 | Dec 07, 2021, 05:46 PM |
| Kunin Audrey | Chief Product Officer | Dec 03, 2021 | Buy | $0.46 | 101,650 | 47,013 | 500,000 | Dec 07, 2021, 05:43 PM |
| Hall Justin | CEO, GC and Director | Dec 06, 2021 | Buy | $0.43 | 69,767 | 30,000 | 73,172 | Dec 06, 2021, 08:03 PM |
| Kunin Jeffrey | President, DERMAdoctor, LLC | Dec 02, 2021 | Buy | $0.48 | 262,369 | 124,888 | 398,350 | Dec 06, 2021, 04:31 PM |
| Kunin Audrey | Chief Product Officer | Dec 02, 2021 | Buy | $0.48 | 262,369 | 124,888 | 398,350 | Dec 06, 2021, 04:31 PM |
| Jones Andrew D. | CFO | Dec 03, 2021 | Buy | $0.44 | 8,690 | 3,824 | 90,696 | Dec 06, 2021, 04:30 PM |
| Jones Andrew D. | CFO | Dec 06, 2021 | Buy | $0.44 | 36,765 | 16,177 | 127,461 | Dec 06, 2021, 04:30 PM |
| Kunin Audrey | Chief Product Officer | Dec 01, 2021 | Buy | $0.49 | 14,848 | 7,276 | 135,981 | Dec 03, 2021, 04:30 PM |
| Kunin Jeffrey | President, DERMAdoctor, LLC | Dec 01, 2021 | Buy | $0.49 | 14,848 | 7,276 | 135,981 | Dec 03, 2021, 04:30 PM |
| Kunin Jeffrey | President, DERMAdoctor, LLC | Nov 30, 2021 | Buy | $0.46 | 30,000 | 13,800 | 121,133 | Dec 02, 2021, 04:30 PM |
| Kunin Audrey | Chief Product Officer | Nov 30, 2021 | Buy | $0.46 | 30,000 | 13,800 | 121,133 | Dec 02, 2021, 04:30 PM |
| Kunin Audrey | Chief Product Officer | Nov 23, 2021 | Buy | $0.46 | 66,133 | 30,368 | 91,133 | Nov 24, 2021, 04:46 PM |
| Kunin Audrey | Chief Product Officer | Nov 22, 2021 | Buy | $0.46 | 25,000 | 11,500 | 25,000 | Nov 24, 2021, 04:46 PM |
| Kunin Jeffrey | President, DERMAdoctor, LLC | Nov 23, 2021 | Buy | $0.46 | 66,133 | 30,368 | 91,133 | Nov 24, 2021, 04:46 PM |
| Kunin Jeffrey | President, DERMAdoctor, LLC | Nov 22, 2021 | Buy | $0.46 | 25,000 | 11,500 | 25,000 | Nov 24, 2021, 04:46 PM |
| WU MIJIA | Director | Aug 17, 2020 | Option Exercise | $0.30 | 20,000 | 6,000 | 20,000 | Aug 19, 2020, 04:24 PM |
| WU MIJIA | Director | Aug 17, 2020 | Sale | $1.35 | 20,000 | 27,000 | 0 | Aug 19, 2020, 04:24 PM |
| Fu Jian Ping | 10% Owner | Aug 01, 2020 | Sale | $1.23 | 1,302,350 | 1,601,891 | 4,000,000 | Aug 04, 2020, 06:04 PM |
| Raleigh Jason Philip | Interim CFO and Treasurer | Jun 11, 2019 | Option Exercise | $2.35 | 9,750 | 22,912 | 9,750 | Oct 28, 2019, 04:30 PM |
| Raleigh Jason Philip | Interim CFO and Treasurer | Jun 10, 2019 | Option Exercise | $2.20 | 23,405 | 51,491 | 23,405 | Oct 28, 2019, 04:30 PM |
| Raleigh Jason Philip | Interim CFO and Treasurer | Jun 10, 2019 | Sale | $3.00 | 23,405 | 70,215 | 0 | Oct 28, 2019, 04:30 PM |
| Raleigh Jason Philip | Interim CFO and Treasurer | Jun 11, 2019 | Sale | $3.75 | 9,750 | 36,563 | 0 | Oct 28, 2019, 04:30 PM |
| Hall Justin | Interim President & CEO and GC | Jun 10, 2019 | Option Exercise | $2.02 | 47,500 | 95,950 | 50,905 | Oct 28, 2019, 04:29 PM |
| Hall Justin | Interim President & CEO and GC | Jun 10, 2019 | Sale | $3.03 | 47,500 | 143,925 | 3,405 | Oct 28, 2019, 04:29 PM |
| Fu Jian Ping | 10% Owner | Jun 11, 2019 | Sale | $3.84 | 380,954 | 1,462,863 | 5,302,350 | Jun 13, 2019, 09:46 PM |
| Pioneer Pharma (Hong Kong) Co Ltd | 10% Owner | Jun 11, 2019 | Sale | $4.04 | 24,326 | 98,277 | 5,188,421 | Jun 13, 2019, 09:32 PM |
| WU MIJIA | Director | Jun 11, 2019 | Sale | $4.04 | 15,873 | 64,127 | 0 | Jun 13, 2019, 06:03 AM |
| WU MIJIA | Director | Jun 10, 2019 | Sale | $2.03 | 47,619 | 96,667 | 0 | Jun 13, 2019, 06:03 AM |
| Fu Jian Ping | 10% Owner | Oct 11, 2016 | Option Exercise | $3.15 | 126,985 | 400,003 | 3,983,304 | Oct 11, 2016, 06:44 PM |
| SIECZKAREK MARK M | CEO | Sep 30, 2016 | Option Exercise | $1.91 | 273,447 | 522,284 | 988,945 | Oct 03, 2016, 04:32 PM |
| WU MIJIA | Director | Sep 30, 2016 | Option Exercise | $3.15 | 15,873 | 50,000 | 47,619 | Oct 03, 2016, 04:24 PM |
| Fu Jian Ping | 10% Owner | Sep 22, 2016 | Option Exercise | $1.91 | 968,587 | 1,850,001 | 3,856,319 | Sep 26, 2016, 06:14 PM |
| Pioneer Pharma (Singapore) Pte. Ltd. | 10% Owner | Sep 22, 2016 | Option Exercise | $1.91 | 1,308,902 | 2,500,003 | 5,188,421 | Sep 26, 2016, 06:05 PM |
| Pioneer Pharma (Singapore) Pte. Ltd. | 10% Owner | Sep 22, 2016 | Option Exercise | $1.81 | 181,300 | 328,153 | 3,879,519 | Sep 26, 2016, 05:45 PM |
| Pioneer Pharma (Singapore) Pte. Ltd. | 10% Owner | Aug 01, 2016 | Option Exercise | $1.91 | 1,308,901 | 2,500,001 | 3,698,219 | Aug 02, 2016, 01:26 PM |
| SIECZKAREK MARK M | CEO | Aug 01, 2016 | Option Exercise | $1.91 | 261,780 | 500,000 | 715,498 | Aug 02, 2016, 01:18 PM |
| Fu Jian Ping | 10% Owner | May 09, 2016 | Option Exercise | $1.91 | 1,937,173 | 3,700,000 | 2,887,732 | May 16, 2016, 02:03 PM |
| Pioneer Pharma (Singapore) Pte. Ltd. | 10% Owner | May 09, 2016 | Option Exercise | $1.91 | 1,308,901 | 2,500,001 | 2,389,318 | May 13, 2016, 05:17 PM |
| SIECZKAREK MARK M | Director | May 09, 2016 | Option Exercise | $1.91 | 261,780 | 500,000 | 453,718 | May 13, 2016, 02:55 PM |
| SIECZKAREK MARK M | Director | Feb 25, 2016 | Option Exercise | $1.91 | 125,387 | 239,489 | 133,246 | Feb 26, 2016, 09:08 PM |
| Pioneer Pharma (Singapore) Pte. Ltd. | 10% Owner | Feb 25, 2016 | Option Exercise | $1.91 | 696,590 | 1,330,487 | 1,104,742 | Feb 26, 2016, 09:07 PM |
| Najafi Ramin | Chief Executive Officer | Aug 20, 2015 | Buy | $0.44 | 6,000 | 2,640 | 12,000 | Aug 21, 2015, 04:03 PM |
| Najafi Ramin | Chief Executive Officer | Aug 19, 2015 | Buy | $0.50 | 6,000 | 3,000 | 6,000 | Aug 21, 2015, 04:03 PM |
| SIECZKAREK MARK M | Director | Mar 03, 2015 | Buy | $0.60 | 166,666 | 100,000 | 196,466 | Mar 05, 2015, 06:01 PM |
| Najafi Ramin | Chief Executive Officer | Mar 03, 2015 | Buy | $0.60 | 166,666 | 100,000 | 3,391,666 | Mar 05, 2015, 05:44 PM |
| Pioneer Pharma (Singapore) Pte. Ltd. | 10% Owner | Mar 03, 2015 | Buy | $0.60 | 2,590,000 | 1,554,000 | 9,595,656 | Mar 05, 2015, 05:01 PM |
| Stroman David W. | SVP, Ophthalmic Product Devt. | Dec 12, 2014 | Buy | $0.66 | 10,000 | 6,600 | 23,000 | Dec 16, 2014, 10:05 AM |
| PAULSON THOMAS J | CFO | Dec 12, 2014 | Buy | $0.68 | 10,000 | 6,800 | 68,210 | Dec 15, 2014, 01:14 PM |
| Najafi Ramin | Chief Executive Officer | Dec 12, 2014 | Buy | $0.65 | 50,000 | 32,500 | 3,225,000 | Dec 15, 2014, 01:04 PM |
| PAULSON THOMAS J | CFO | Dec 09, 2014 | Buy | $0.67 | 10,000 | 6,700 | 58,210 | Dec 11, 2014, 12:51 PM |
| Najafi Ramin | Chief Executive Officer | Dec 11, 2014 | Buy | $0.60 | 20,000 | 12,000 | 3,175,000 | Dec 11, 2014, 12:43 PM |
| Najafi Ramin | Chief Executive Officer | Dec 05, 2014 | Buy | $0.65 | 25,000 | 16,250 | 3,155,000 | Dec 08, 2014, 05:10 PM |
| Najafi Ramin | Chief Executive Officer | Dec 02, 2014 | Buy | $0.71 | 18,000 | 12,780 | 3,130,000 | Dec 04, 2014, 05:15 PM |
| Wicks Tony D.S. | Director | Dec 02, 2014 | Sale | $0.70 | 20,000 | 14,000 | 213,660 | Dec 04, 2014, 04:52 PM |
| Wicks Tony D.S. | Director | Dec 01, 2014 | Sale | $0.69 | 10,000 | 6,900 | 213,680 | Dec 03, 2014, 04:56 PM |
| SIECZKAREK MARK M | Director | Jun 04, 2014 | Buy | $0.89 | 4,800 | 4,272 | 29,800 | Jun 05, 2014, 07:53 PM |
| SIECZKAREK MARK M | Director | May 19, 2014 | Buy | $0.88 | 25,000 | 22,000 | 25,000 | May 21, 2014, 08:20 PM |
| China Pioneer Pharma Holdings Ltd | 10% Owner | May 13, 2014 | Buy | $0.99 | 65,065 | 64,414 | 608,156 | May 14, 2014, 05:22 PM |
| China Pioneer Pharma Holdings Ltd | 10% Owner | May 12, 2014 | Buy | $0.99 | 116,107 | 114,946 | 543,091 | May 14, 2014, 05:17 PM |
| China Pioneer Pharma Holdings Ltd | 10% Owner | May 09, 2014 | Buy | $0.99 | 318,828 | 315,640 | 426,984 | May 14, 2014, 05:10 PM |
| Wicks Tony D.S. | Director | Apr 14, 2014 | Option Exercise | $0.56 | 52,000 | 29,120 | 213,690 | Apr 14, 2014, 02:48 PM |
| Dailley Anthony | Director | Mar 17, 2014 | Option Exercise | $0.56 | 9,000 | 5,040 | 285,259 | Mar 21, 2014, 07:24 PM |
| China Pioneer Pharma Holdings Ltd | 10% Owner | Dec 02, 2013 | Buy | $1.14 | 5,000,000 | 5,700,000 | 7,005,656 | Dec 04, 2013, 06:52 PM |
| Pioneer Pharma (Singapore) Pte. Ltd. | 10% Owner | Dec 02, 2013 | Buy | $1.14 | 5,000,000 | 5,700,000 | 7,005,656 | Dec 04, 2013, 06:00 PM |
| Pioneer Pharma (Hong Kong) Co Ltd | 10% Owner | Dec 02, 2013 | Buy | $1.14 | 5,000,000 | 5,700,000 | 7,005,656 | Dec 04, 2013, 05:59 PM |
| China Pioneer Pharma Holdings Ltd | 10% Owner | Nov 14, 2013 | Buy | $1.02 | 108,156 | 110,319 | 108,156 | Dec 02, 2013, 04:25 PM |
| Li Xinzhou | 10% Owner | Sep 20, 2013 | Sale | $1.87 | 120,000 | 224,988 | 0 | Dec 02, 2013, 02:42 PM |
| Najafi Ramin | Chief Executive Officer | Oct 28, 2013 | Option Exercise | $1.75 | 4,557 | 7,975 | 100,195 | Oct 29, 2013, 08:42 PM |
| PAULSON THOMAS J | CFO | Oct 28, 2013 | Option Exercise | $1.75 | 3,645 | 6,379 | 63,855 | Oct 29, 2013, 08:27 PM |
| Li Xinzhou | 10% Owner | Dec 11, 2012 | Buy | $1.20 | 120,000 | 144,000 | 2,120,000 | Jan 03, 2013, 01:17 PM |
| Li Xinzhou | 10% Owner | Oct 31, 2012 | Buy | $1.25 | 1,200,000 | 1,500,000 | 2,000,000 | Jan 02, 2013, 03:25 PM |
| Li Xinzhou | 10% Owner | Sep 13, 2012 | Buy | $1.25 | 800,000 | 1,000,000 | 800,000 | Jan 02, 2013, 03:17 PM |
| Stroman David W. | SVP, Ophthalmic Product Devt. | Dec 06, 2012 | Buy | $1.24 | 10,000 | 12,400 | 22,000 | Dec 10, 2012, 08:17 PM |
| PAULSON THOMAS J | CFO | Dec 06, 2012 | Buy | $1.24 | 10,000 | 12,400 | 63,855 | Dec 10, 2012, 08:06 PM |
| Najafi Ramin | Chief Executive Officer | Dec 06, 2012 | Buy | $1.24 | 20,000 | 24,800 | 100,195 | Dec 10, 2012, 08:01 PM |
| PAULSON THOMAS J | CFO | Oct 27, 2012 | Option Exercise | $1.31 | 3,645 | 4,775 | 53,855 | Dec 04, 2012, 01:50 PM |
| Najafi Ramin | Chief Executive Officer | Oct 27, 2012 | Option Exercise | $1.31 | 4,557 | 5,970 | 80,195 | Dec 04, 2012, 01:50 PM |
| NAQU AREA PIONEER PHARMA CO., LTD. | 10% Owner | Oct 31, 2012 | Buy | $1.25 | 1,200,000 | 1,500,000 | 2,000,000 | Nov 20, 2012, 02:14 PM |
| Pioneer Pharma (Singapore) Pte. Ltd. | 10% Owner | Oct 31, 2012 | Buy | $1.25 | 1,200,000 | 1,500,000 | 2,000,000 | Nov 05, 2012, 02:12 PM |
| Tufts Robert R. | Director | Sep 27, 2012 | Option Exercise | $0.56 | 28,500 | 15,960 | 348,408 | Nov 01, 2012, 07:35 PM |
| PAULSON THOMAS J | CFO | May 30, 2012 | Buy | $0.94 | 10,000 | 9,364 | 17,500 | May 31, 2012, 06:27 PM |
| Najafi Ramin | Chief Executive Officer | May 29, 2012 | Buy | $0.96 | 6,000 | 5,756 | 34,752 | May 30, 2012, 04:52 PM |
| Najafi Ramin | Chief Executive Officer | May 25, 2012 | Buy | $0.99 | 3,500 | 3,465 | 28,752 | May 29, 2012, 02:09 PM |
| Freiman Paul E. | Director | Dec 29, 2011 | Option Exercise | $0.20 | 30,000 | 6,000 | 45,137 | Jan 05, 2012, 04:19 PM |
| Najafi Ramin | Chief Executive Officer | Oct 27, 2011 | Option Exercise | $1.09 | 50,000 | 54,500 | 202,673 | Nov 01, 2011, 06:24 PM |
| PAULSON THOMAS J | CFO | Oct 27, 2011 | Option Exercise | $1.09 | 40,000 | 43,600 | 40,000 | Nov 01, 2011, 06:02 PM |
| Najafi Ramin | Chief Executive Officer | Sep 29, 2011 | Option Exercise | $0.90 | 152,673 | 137,406 | 177,925 | Oct 03, 2011, 04:04 PM |
| Freiman Paul E. | Director | Sep 12, 2011 | Buy | $0.84 | 3,000 | 2,520 | 15,137 | Sep 13, 2011, 07:52 PM |
| PAULSON THOMAS J | CFO | Aug 26, 2011 | Buy | $0.86 | 3,500 | 3,010 | 7,500 | Aug 29, 2011, 02:20 PM |
| Najafi Ramin | Chief Executive Officer | Aug 16, 2011 | Buy | $0.85 | 10,000 | 8,500 | 25,252 | Aug 16, 2011, 07:40 PM |
| Tufts Robert R. | Director | Aug 15, 2011 | Buy | $0.85 | 5,000 | 4,242 | 319,908 | Aug 16, 2011, 04:37 PM |
| Najafi Ramin | Chief Executive Officer | May 27, 2011 | Buy | $1.59 | 500 | 797 | 15,252 | May 31, 2011, 03:55 PM |
| Khosrovi Behzad | VP Research and Development | May 27, 2011 | Buy | $1.64 | 1,000 | 1,644 | 136,000 | May 31, 2011, 03:53 PM |
| McPherson T. Alex | Director | May 27, 2011 | Buy | $1.65 | 6,200 | 10,217 | 6,700 | May 27, 2011, 04:38 PM |
| Najafi Ramin | Chief Executive Officer | May 26, 2011 | Buy | $1.60 | 1,000 | 1,597 | 14,752 | May 27, 2011, 12:08 PM |
| Najafi Ramin | Chief Executive Officer | May 24, 2011 | Buy | $1.71 | 2,552 | 4,371 | 13,752 | May 26, 2011, 05:03 PM |
| Najafi Ramin | Chief Executive Officer | Sep 02, 2008 | Buy | $1.98 | 1,000 | 1,980 | 7,200 | Feb 01, 2011, 06:01 PM |
| Freiman Paul E. | Director | Aug 16, 2010 | Sale | $1.83 | 15,000 | 27,450 | 12,137 | Aug 18, 2010, 01:46 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Kunin Audrey | Chief Product Officer | 12/06/2022 | 2 |
| Kunin Jeffrey | President, DERMAdoctor, LLC | 12/06/2022 | 2 |
| Kunin Audrey | Chief Product Officer | 11/21/2022 | 12,545 |
| Kunin Jeffrey | President, DERMAdoctor, LLC | 11/21/2022 | 12,545 |
| Kunin Audrey | Chief Product Officer | 11/21/2022 | 12,545 |
| Kunin Jeffrey | President, DERMAdoctor, LLC | 11/21/2022 | 12,545 |
| Hall Justin | CEO, GC and Director | 09/14/2022 | 1,500 |
| Kunin Jeffrey | President, DERMAdoctor, LLC | 09/14/2022 | 46,094 |
| Kunin Audrey | Chief Product Officer | 09/14/2022 | 46,094 |
| Kunin Jeffrey | President, DERMAdoctor, LLC | 12/03/2021 | 47,013 |
| Kunin Audrey | Chief Product Officer | 12/03/2021 | 47,013 |
| Hall Justin | CEO, GC and Director | 12/06/2021 | 30,000 |
| Kunin Jeffrey | President, DERMAdoctor, LLC | 12/02/2021 | 124,888 |
| Kunin Audrey | Chief Product Officer | 12/02/2021 | 124,888 |
| Jones Andrew D. | CFO | 12/03/2021 | 3,824 |
| Jones Andrew D. | CFO | 12/06/2021 | 16,177 |
| Kunin Audrey | Chief Product Officer | 12/01/2021 | 7,276 |
| Kunin Jeffrey | President, DERMAdoctor, LLC | 12/01/2021 | 7,276 |
| Kunin Jeffrey | President, DERMAdoctor, LLC | 11/30/2021 | 13,800 |
| Kunin Audrey | Chief Product Officer | 11/30/2021 | 13,800 |
| Kunin Audrey | Chief Product Officer | 11/23/2021 | 30,368 |
| Kunin Audrey | Chief Product Officer | 11/22/2021 | 11,500 |
| Kunin Jeffrey | President, DERMAdoctor, LLC | 11/23/2021 | 30,368 |
| Kunin Jeffrey | President, DERMAdoctor, LLC | 11/22/2021 | 11,500 |
| WU MIJIA | Director | 08/17/2020 | 6,000 |
| WU MIJIA | Director | 08/17/2020 | 27,000 |
| Fu Jian Ping | 10% Owner | 08/01/2020 | 1,601,891 |
| Raleigh Jason Philip | Interim CFO and Treasurer | 06/11/2019 | 22,912 |
| Raleigh Jason Philip | Interim CFO and Treasurer | 06/10/2019 | 51,491 |
| Raleigh Jason Philip | Interim CFO and Treasurer | 06/10/2019 | 70,215 |
| Raleigh Jason Philip | Interim CFO and Treasurer | 06/11/2019 | 36,563 |
| Hall Justin | Interim President & CEO and GC | 06/10/2019 | 95,950 |
| Hall Justin | Interim President & CEO and GC | 06/10/2019 | 143,925 |
| Fu Jian Ping | 10% Owner | 06/11/2019 | 1,462,863 |
| Pioneer Pharma (Hong Kong) Co Ltd | 10% Owner | 06/11/2019 | 98,277 |
| WU MIJIA | Director | 06/11/2019 | 64,127 |
| WU MIJIA | Director | 06/10/2019 | 96,667 |
| Fu Jian Ping | 10% Owner | 10/11/2016 | 400,003 |
| SIECZKAREK MARK M | CEO | 09/30/2016 | 522,284 |
| WU MIJIA | Director | 09/30/2016 | 50,000 |
| Fu Jian Ping | 10% Owner | 09/22/2016 | 1,850,001 |
| Pioneer Pharma (Singapore) Pte. Ltd. | 10% Owner | 09/22/2016 | 2,500,003 |
| Pioneer Pharma (Singapore) Pte. Ltd. | 10% Owner | 09/22/2016 | 328,153 |
| Pioneer Pharma (Singapore) Pte. Ltd. | 10% Owner | 08/01/2016 | 2,500,001 |
| SIECZKAREK MARK M | CEO | 08/01/2016 | 500,000 |
| Fu Jian Ping | 10% Owner | 05/09/2016 | 3,700,000 |
| Pioneer Pharma (Singapore) Pte. Ltd. | 10% Owner | 05/09/2016 | 2,500,001 |
| SIECZKAREK MARK M | Director | 05/09/2016 | 500,000 |
| SIECZKAREK MARK M | Director | 02/25/2016 | 239,489 |
| Pioneer Pharma (Singapore) Pte. Ltd. | 10% Owner | 02/25/2016 | 1,330,487 |
| Najafi Ramin | Chief Executive Officer | 08/20/2015 | 2,640 |
| Najafi Ramin | Chief Executive Officer | 08/19/2015 | 3,000 |
| SIECZKAREK MARK M | Director | 03/03/2015 | 100,000 |
| Najafi Ramin | Chief Executive Officer | 03/03/2015 | 100,000 |
| Pioneer Pharma (Singapore) Pte. Ltd. | 10% Owner | 03/03/2015 | 1,554,000 |
| Stroman David W. | SVP, Ophthalmic Product Devt. | 12/12/2014 | 6,600 |
| PAULSON THOMAS J | CFO | 12/12/2014 | 6,800 |
| Najafi Ramin | Chief Executive Officer | 12/12/2014 | 32,500 |
| PAULSON THOMAS J | CFO | 12/09/2014 | 6,700 |
| Najafi Ramin | Chief Executive Officer | 12/11/2014 | 12,000 |
| Najafi Ramin | Chief Executive Officer | 12/05/2014 | 16,250 |
| Najafi Ramin | Chief Executive Officer | 12/02/2014 | 12,780 |
| Wicks Tony D.S. | Director | 12/02/2014 | 14,000 |
| Wicks Tony D.S. | Director | 12/01/2014 | 6,900 |
| SIECZKAREK MARK M | Director | 06/04/2014 | 4,272 |
| SIECZKAREK MARK M | Director | 05/19/2014 | 22,000 |
| China Pioneer Pharma Holdings Ltd | 10% Owner | 05/13/2014 | 64,414 |
| China Pioneer Pharma Holdings Ltd | 10% Owner | 05/12/2014 | 114,946 |
| China Pioneer Pharma Holdings Ltd | 10% Owner | 05/09/2014 | 315,640 |
| Wicks Tony D.S. | Director | 04/14/2014 | 29,120 |
| Dailley Anthony | Director | 03/17/2014 | 5,040 |
| China Pioneer Pharma Holdings Ltd | 10% Owner | 12/02/2013 | 5,700,000 |
| Pioneer Pharma (Singapore) Pte. Ltd. | 10% Owner | 12/02/2013 | 5,700,000 |
| Pioneer Pharma (Hong Kong) Co Ltd | 10% Owner | 12/02/2013 | 5,700,000 |
| China Pioneer Pharma Holdings Ltd | 10% Owner | 11/14/2013 | 110,319 |
| Li Xinzhou | 10% Owner | 09/20/2013 | 224,988 |
| Najafi Ramin | Chief Executive Officer | 10/28/2013 | 7,975 |
| PAULSON THOMAS J | CFO | 10/28/2013 | 6,379 |
| Li Xinzhou | 10% Owner | 12/11/2012 | 144,000 |
| Li Xinzhou | 10% Owner | 10/31/2012 | 1,500,000 |
| Li Xinzhou | 10% Owner | 09/13/2012 | 1,000,000 |
| Stroman David W. | SVP, Ophthalmic Product Devt. | 12/06/2012 | 12,400 |
| PAULSON THOMAS J | CFO | 12/06/2012 | 12,400 |
| Najafi Ramin | Chief Executive Officer | 12/06/2012 | 24,800 |
| PAULSON THOMAS J | CFO | 10/27/2012 | 4,775 |
| Najafi Ramin | Chief Executive Officer | 10/27/2012 | 5,970 |
| NAQU AREA PIONEER PHARMA CO., LTD. | 10% Owner | 10/31/2012 | 1,500,000 |
| Pioneer Pharma (Singapore) Pte. Ltd. | 10% Owner | 10/31/2012 | 1,500,000 |
| Tufts Robert R. | Director | 09/27/2012 | 15,960 |
| PAULSON THOMAS J | CFO | 05/30/2012 | 9,364 |
| Najafi Ramin | Chief Executive Officer | 05/29/2012 | 5,756 |
| Najafi Ramin | Chief Executive Officer | 05/25/2012 | 3,465 |
| Freiman Paul E. | Director | 12/29/2011 | 6,000 |
| Najafi Ramin | Chief Executive Officer | 10/27/2011 | 54,500 |
| PAULSON THOMAS J | CFO | 10/27/2011 | 43,600 |
| Najafi Ramin | Chief Executive Officer | 09/29/2011 | 137,406 |
| Freiman Paul E. | Director | 09/12/2011 | 2,520 |
| PAULSON THOMAS J | CFO | 08/26/2011 | 3,010 |
| Najafi Ramin | Chief Executive Officer | 08/16/2011 | 8,500 |
| Tufts Robert R. | Director | 08/15/2011 | 4,242 |
| Najafi Ramin | Chief Executive Officer | 05/27/2011 | 797 |
| Khosrovi Behzad | VP Research and Development | 05/27/2011 | 1,644 |
| McPherson T. Alex | Director | 05/27/2011 | 10,217 |
| Najafi Ramin | Chief Executive Officer | 05/26/2011 | 1,597 |
| Najafi Ramin | Chief Executive Officer | 05/24/2011 | 4,371 |
| Najafi Ramin | Chief Executive Officer | 09/02/2008 | 1,980 |
| Freiman Paul E. | Director | 08/16/2010 | 27,450 |
Load More Insider Transactions
FUNDS WITH A POSITION IN NOVABAY PHARMACEUTICALS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 155,523 | 0.00005% | 164.39% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 25,061 | 0% | No change | Other |
| BLACKROCK INC. | 20 | 0% | No change | Other |
CHANGE IN SHARES OUTSTANDING FOR NOVABAY PHARMACEUTICALS INC
STOCK BUYBACKS FOR NOVABAY PHARMACEUTICALS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
-10.17%
1Q
BUYBACK ANNOUNCEMENT(S) FOR NOVABAY PHARMACEUTICALS INC
LOADING...